Osteoarthritis Trial, Recruiting NCT06118892 Sponsor: Moximed Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06118892
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 25 and 65 years old at the time of the procedure
  • Your Body Mass Index (BMI) is under 35 (a measure of body weight relative to height)
  • You have knee pain that gets worse with activity and is focused specifically on the inner side of the knee, not the whole knee
  • Your knee pain score on a standard questionnaire called WOMAC is 40 or higher, meaning moderate to severe pain
  • You have already tried non-surgical treatments for knee arthritis (such as physical therapy or medication) without enough relief

Who may not be able to join:

  • You have large bony growths or significant tissue bulging inside the knee that could interfere with the device being used in the trial (confirm with trial site)
  • You have poor bone quality, such as bone loss, weak bones, or osteoporosis
  • The ligaments in your knee are unstable or loose
  • You have a current or recent knee infection
  • You have an inflammatory joint condition, including joint problems caused by a viral infection
  • You have a known or suspected allergy to cobalt, chromium, nickel, or other metals
  • You have a history of raised, thick, or tight scarring (such as keloid or hypertrophic scars)
  • You have a tendency to form excessive scar tissue or internal adhesions after previous procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Moximed
Registry
ClinicalTrials.gov
Start date
3 November 2023
Est. completion
30 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Freedom from device- and procedure-related Subsequent Surgical Interventions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov